ALEXANDRIA, Va., Sept. 17 -- United States Patent no. 12,414,945, issued on Sept. 16, was assigned to Eisai R&D Management Co. Ltd. (Tokyo).

"Therapeutic agent for breast cancer" was invented by Saori Miyano (Tsukuba, Japan), Yuji Yamamoto (Tsukuba, Japan) and Takayuki Nakagawa (Tsukuba, Japan).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present application discloses a therapeutic agent for breast cancer, comprising 5-((2-(4-(1-(2-hydroxyethyl)piperidin-4-yl)benzamide)pyridin-4-yl)oxy)-6-(2-methoxyethoxy)-N-methyl-1H-indole-1-carboxamide or a pharmacologically acceptable salt thereof."

The patent was filed on Dec. 15, 2016, under Application No. 15/771,193.

*For further information, including images,...